Eleclazine (C007B-148804)

Product Application：ELECLAZINE is a late sodium current inhibitor and a phase II agent with demonstrated pre-clinical anti-ischemic and antiarrhythmic properties. Specification: 0.97 Molecular Formula: C21H16F3N3O3 Molecular Weight: 415.372 PubChem CID: 71183216 Isomeric SMILES: C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/E174249-SCI_924edd5c225ac5398aaa22d4a427c64e.pdf

UPC:

51142025

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

E174249-25mg

CAS:

1443211-72-0

Product Size:

25mg

Hazard Statement Codes:

H302:H315:H319:H335

Precautionary Statement Codes:

P261:P305+P351+P338